Write an article critique on: Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.

Journal club

Write an article critique on: Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes by Juan P. Frías, M.D., Melanie J. Davies, M.D., Julio Rosenstock, M.D.,
Federico C. Pérez Manghi, M.D., Laura Fernández Landó, M.D.,
Brandon K. Bergman, Pharm.D., Bing Liu, Ph.D., Xuewei Cui, Ph.D.,
and Katelyn Brown, Pharm.D., for the SURPASS-2 Investigators

Write an article critique on: Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
Scroll to top